Our services
Research and insights that help life science companies succeed in Asia-Pacific
H-Research Asia provides decision-focused healthcare research for life science teams across Asia-Pacific. Clients work with us to answer clear business questions within defined markets, covering market access, launch preparation, and post-launch optimisation.
Market access and value insight
Access decisions in Asia depend on how payers assess value, what evidence they expect, and where affordability limits sit. We clarify these factors so teams understand what is achievable in each market and where the main risks lie.
This work is used to support decisions such as:
-
Setting realistic pricing and affordability levels
-
Local evidence needs for value discussions and reimbursement decisions
-
Mapping reimbursement and formulary pathways in public and private systems
-
Identifying payer concerns and access barriers
-
Designing or refining patient access programmes
-
The output informs access strategy, evidence planning, and payer engagement within target countries.
Launch and brand strategy insight
Launch success depends on how patients move through care, how clinicians make treatment choices, and who influences adoption. We analyse these factors at country level and translate them into practical launch decisions.
This work is used to support decisions such as:
-
Confirming market potential in selected countries
-
Understanding competitive pressure and likely responses
-
Mapping treatment flows and patient pathways
-
Identifying key influencers and KOL roles
-
Shaping positioning and early messaging
-
Supporting local licensing or partnering discussions
-
The output supports regional strategy development and affiliate-level launch planning.
Performance tracking and evidence generation
After launch, performance changes for specific reasons such as access progress, competitive activity, message fit, and execution gaps. We track what is changing and explain why, so teams know what to adjust.
This work is used to support decisions such as:
-
Monitoring brand performance and equity over time
-
Understanding prescribing behaviour and patient share changes
-
Refining messages for specific segments
-
Assessing sales force focus and effectiveness
-
Adjusting value messages for public market entry where relevant
Findings are translated into clear actions for strategy and execution.
